Circulation. 2002;105:1943-1948
Published online before print April 1, 2002, doi: 10.1161/01.CIR.0000014448.19052.4C
Published online before print April 1, 2002, doi: 10.1161/01.CIR.0000014448.19052.4C
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2002;105:1943.)
© 2002 American Heart Association, Inc.
Clinical Investigation and Reports |
Allelic Variants in Long-QT Disease Genes in Patients With Drug-Associated Torsades de Pointes
From the Departments of Medicine and Pharmacology (P.Y., H.K., B.D., T.Y., J.W., P.C.V., K.T.M., K.N., A.L.G., D.M.R.), Vanderbilt University School of Medicine, Nashville, Tenn; Cardiology Division (S.H.H.), Johann Wolfgang Goethe University, Frankfurt, Germany; National Cardiology Center (W.S.), Osaka, Japan; Department of Cardiology (P.J.S.), Policlinico S. Matteo, Istituto di Ricovero e Cura a Carattere Scientifico, Pavia, Italy; and Medtronic Inc (M.S.), Minneapolis, Minn.
Correspondence to Dan M. Roden, MD, Professor of Medicine and Pharmacology, Director, Division of Clinical Pharmacology, 532 Medical Research Bldg I, Vanderbilt University School of Medicine, Nashville, TN 37232. E-mail dan.roden{at}mcmail.vanderbilt.edu
Background— DNA variants appearing to predispose to drug-associated "acquired" long-QT syndrome (aLQTS) have been reported in congenital long-QT disease genes. However, the incidence of these genetic risk factors has not been systematically evaluated in a large set of patients with aLQTS. We have previously identified functionally important DNA variants in genes encoding K+ channel ancillary subunits in 11% of an aLQTS cohort.
Methods and Results— The coding regions of the genes encoding the pore-forming channel proteins KvLQT1, HERG, and SCN5A were screened in (1) the same aLQTS cohort (n=92) and (2) controls, drawn from patients tolerating QT-prolonging drugs (n=67) and cross sections of the Middle Tennessee (n=71) and US populations (n=90). The frequency of three common nonsynonymous coding region polymorphisms was no different between aLQTS and control subjects, as follows: 24% versus 19% for H558R (SCN5A), 3% versus 3% for R34C (SCN5A), and 14% versus 14% for K897T (HERG). Missense mutations (absent in controls) were identified in 5 of 92 patients. KvLQT1 and HERG mutations (one each) reduced K+ currents in vitro, consistent with the idea that they augment risk for aLQTS. However, three SCN5A variants did not alter INa, which argues that they played no role in the aLQTS phenotype.
Conclusions— DNA variants in the coding regions of congenital long-QT disease genes predisposing to aLQTS can be identified in 
10% to 15% of affected subjects, predominantly in genes encoding ancillary subunits.
Key Words: arrhythmia • genetics • drugs • long-QT syndrome
This article has been cited by other articles:
 |
|
 |
|
  H. Itoh, T. Sakaguchi, W.-G. Ding, E. Watanabe, I. Watanabe, Y. Nishio, T. Makiyama, S. Ohno, M. Akao, Y. Higashi, et al. Latent Genetic Backgrounds and Molecular Pathogenesis in Drug-Induced Long-QT Syndrome Circ Arrhythm Electrophysiol, October 1, 2009; 2(5): 511 - 523. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. S. Kaufman Disease-Causing Polymorphisms in the Spectrum of Long QT Syndrome Mutations. J. Am. Coll. Cardiol., August 25, 2009; 54(9): 820 - 821. [Full Text] [PDF]
|
|
|
|
|
|
T. Yang, S.-K. Chung, W. Zhang, J. G.L. Mullins, C. H. McCulley, J. Crawford, J. MacCormick, C.-A. Eddy, A. N. Shelling, J. K. French, et al. Biophysical Properties of 9 KCNQ1 Mutations Associated With Long-QT Syndrome Circ Arrhythm Electrophysiol, August 1, 2009; 2(4): 417 - 426. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. E. Odening, O. Hyder, L. Chaves, L. Schofield, M. Brunner, M. Kirk, M. Zehender, X. Peng, and G. Koren Pharmacogenomics of anesthetic drugs in transgenic LQT1 and LQT2 rabbits reveal genotype-specific differential effects on cardiac repolarization Am J Physiol Heart Circ Physiol, December 1, 2008; 295(6): H2264 - H2272. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. Noseworthy and C. Newton-Cheh Genetic Determinants of Sudden Cardiac Death Circulation, October 28, 2008; 118(18): 1854 - 1863. [Full Text] [PDF]
|
|
|
|
|
|
D. M. Roden Repolarization Reserve: A Moving Target Circulation, September 2, 2008; 118(10): 981 - 982. [Full Text] [PDF]
|
|
|
|
|
|
L. Xiao, J. Xiao, X. Luo, H. Lin, Z. Wang, and S. Nattel Feedback Remodeling of Cardiac Potassium Current Expression: A Novel Potential Mechanism for Control of Repolarization Reserve Circulation, September 2, 2008; 118(10): 983 - 992. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. V. Hume-Smith, S. Sanatani, J. Lim, A. Chau, and S. D. Whyte The Effect of Propofol Concentration on Dispersion of Myocardial Repolarization in Children Anesth. Analg., September 1, 2008; 107(3): 806 - 810. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Darbar, P. J. Kannankeril, B. S. Donahue, G. Kucera, T. Stubblefield, J. L. Haines, A. L. George Jr, and D. M. Roden Cardiac Sodium Channel (SCN5A) Variants Associated with Atrial Fibrillation Circulation, April 15, 2008; 117(15): 1927 - 1935. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Roden Long-QT Syndrome N. Engl. J. Med., January 10, 2008; 358(2): 169 - 176. [Full Text] [PDF]
|
|
|
|
|
|
C. M. Albert, E. G. Nam, E. B. Rimm, H. W. Jin, R. J. Hajjar, D. J. Hunter, C. A. MacRae, and P. T. Ellinor Cardiac Sodium Channel Gene Variants and Sudden Cardiac Death in Women Circulation, January 1, 2008; 117(1): 16 - 23. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. Whyte, S. Sanatani, J. Lim, and P. D. Booker A Comparison of the Effect on Dispersion of Repolarization of Age-Adjusted MAC Values of Sevoflurane in Children Anesth. Analg., February 1, 2007; 104(2): 277 - 282. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Mohler, S. Le Scouarnec, I. Denjoy, J. S. Lowe, P. Guicheney, L. Caron, I. M. Driskell, J.-J. Schott, K. Norris, A. Leenhardt, et al. Defining the Cellular Phenotype of "Ankyrin-B Syndrome" Variants: Human ANK2 Variants Associated With Clinical Phenotypes Display a Spectrum of Activities in Cardiomyocytes Circulation, January 30, 2007; 115(4): 432 - 441. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Roden, R. B. Altman, N. L. Benowitz, D. A. Flockhart, K. M. Giacomini, J. A. Johnson, R. M. Krauss, H. L. McLeod, M. J. Ratain, M. V. Relling, et al. Pharmacogenomics: Challenges and Opportunities. Ann Intern Med, November 21, 2006; 145(10): 749 - 757. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Schulze-Bahr Arrhythmia Predisposition: Between Rare Disease Paradigms and Common Ion Channel Gene Variants J. Am. Coll. Cardiol., October 27, 2006; 48(9_Suppl_A): A67 - A78. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Developed in Collaboration With the European Heart, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) J. Am. Coll. Cardiol., September 5, 2006; 48(5): 1064 - 1108. [Full Text] [PDF]
|
|
|
|
|
|
Developed in Collaboration With the European Heart, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) J. Am. Coll. Cardiol., September 5, 2006; 48(5): e247 - e346. [Full Text] [PDF]
|
|
|
|
 |
|
 D. P. Zipes, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Eur. Heart J., September 1, 2006; 27(17): 2099 - 2140. [Full Text] [PDF]
|
|
|
|
 |
|
 Writing Committee Members, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Europace, September 1, 2006; 8(9): 746 - 837. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Hinterseer, M. Irlbeck, L. Ney, B.-M. Beckmann, A. Pfeufer, G. Steinbeck, and S. Kaab Acute respiratory distress syndrome with transiently impaired left ventricular function and Torsades de Pointes arrhythmia unmasking congenital long QT syndrome in a 25-yr-old woman Br. J. Anaesth., August 1, 2006; 97(2): 150 - 153. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. G. Priori and C. Napolitano Molecular Underpinning of "Good Luck" Circulation, August 1, 2006; 114(5): 360 - 362. [Full Text] [PDF]
|
|
|
|
|
|
S. Poelzing, C. Forleo, M. Samodell, L. Dudash, S. Sorrentino, M. Anaclerio, R. Troccoli, M. Iacoviello, R. Romito, P. Guida, et al. SCN5A Polymorphism Restores Trafficking of a Brugada Syndrome Mutation on a Separate Gene Circulation, August 1, 2006; 114(5): 368 - 376. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Milan, I. L. Jones, P. T. Ellinor, and C. A. MacRae In vivo recording of adult zebrafish electrocardiogram and assessment of drug-induced QT prolongation Am J Physiol Heart Circ Physiol, July 1, 2006; 291(1): H269 - H273. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. I. Keller, H. Huang, J. Zhao, R. Frank, V. Suarez, E. Delacretaz, M. Brink, S. Osswald, N. Schwick, and M. Chahine A novel SCN5A mutation, F1344S, identified in a patient with Brugada syndrome and fever-induced ventricular fibrillation Cardiovasc Res, June 1, 2006; 70(3): 521 - 529. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Roberts Genomics and Cardiac Arrhythmias J. Am. Coll. Cardiol., January 3, 2006; 47(1): 9 - 21. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Napolitano, S. G. Priori, P. J. Schwartz, R. Bloise, E. Ronchetti, J. Nastoli, G. Bottelli, M. Cerrone, and S. Leonardi Genetic Testing in the Long QT Syndrome: Development and Validation of an Efficient Approach to Genotyping in Clinical Practice JAMA, December 21, 2005; 294(23): 2975 - 2980. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Jespersen, M. Grunnet, and S.-P. Olesen The KCNQ1 Potassium Channel: From Gene to Physiological Function Physiology, December 1, 2005; 20(6): 408 - 416. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Liu, T. Yang, P. C. Viswanathan, and D. M. Roden New Mechanism Contributing to Drug-Induced Arrhythmia: Rescue of a Misprocessed LQT3 Mutant Circulation, November 22, 2005; 112(21): 3239 - 3246. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Crotti, A. L. Lundquist, R. Insolia, M. Pedrazzini, C. Ferrandi, G. M. De Ferrari, A. Vicentini, P. Yang, D. M. Roden, A. L. George Jr, et al. KCNH2-K897T Is a Genetic Modifier of Latent Congenital Long-QT Syndrome Circulation, August 30, 2005; 112(9): 1251 - 1258. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kaab and E. Schulze-Bahr Susceptibility genes and modifiers for cardiac arrhythmias Cardiovasc Res, August 15, 2005; 67(3): 397 - 413. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Roden Proarrhythmia as a pharmacogenomic entity: A critical review and formulation of a unifying hypothesis Cardiovasc Res, August 15, 2005; 67(3): 419 - 425. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Johnson and L. H. Cavallari Cardiovascular pharmacogenomics Exp Physiol, May 1, 2005; 90(3): 283 - 289. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. T. Beery The Genetics of Cardiac Arrhythmias Biol Res Nurs, April 1, 2005; 6(4): 249 - 261. [Abstract] [PDF]
|
|
|
|
 |
|
 Q Wang Author's reply: link of SCN5A SNP R1193Q to long QT syndrome J. Med. Genet., February 1, 2005; 42(2): e8 - e8. [Full Text] [PDF]
|
|
|
|
|
|
T. Aiba, W. Shimizu, M. Inagaki, T. Noda, S. Miyoshi, W.-G. Ding, D. P. Zankov, F. Toyoda, H. Matsuura, M. Horie, et al. Cellular and ionic mechanism for drug-induced long QT syndrome and effectiveness of verapamil J. Am. Coll. Cardiol., January 18, 2005; 45(2): 300 - 307. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Zimetbaum and M. E. Josephson Is There a Role for Maintaining Sinus Rhythm in Patients with Atrial Fibrillation? Ann Intern Med, November 2, 2004; 141(9): 720 - 726. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Kanki, S. Kupershmidt, T. Yang, S. Wells, and D. M. Roden A Structural Requirement for Processing the Cardiac K+ Channel KCNQ1 J. Biol. Chem., August 6, 2004; 279(32): 33976 - 33983. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. D. Anson, M. J. Ackerman, D. J. Tester, M. L. Will, B. P. Delisle, C. L. Anderson, and C. T. January Molecular and functional characterization of common polymorphisms in HERG (KCNH2) potassium channels Am J Physiol Heart Circ Physiol, June 1, 2004; 286(6): H2434 - H2441. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Chugh, O. Senashova, A. Watts, P. T. Tran, Z. Zhou, Q. Gong, J. L. Titus, and S. J. Hayflick Postmortem molecular screening in unexplained sudden death J. Am. Coll. Cardiol., May 5, 2004; 43(9): 1625 - 1629. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q Wang, S Chen, Q Chen, X Wan, J Shen, G A Hoeltge, A A Timur, M T Keating, and G E Kirsch The common SCN5A mutation R1193Q causes LQTS-type electrophysiological alterations of the cardiac sodium channel J. Med. Genet., May 1, 2004; 41(5): e66 - e66. [Full Text] [PDF]
|
|
|
|
|
|
P. Westenskow, I. Splawski, K. W. Timothy, M. T. Keating, and M. C. Sanguinetti Compound Mutations: A Common Cause of Severe Long-QT Syndrome Circulation, April 20, 2004; 109(15): 1834 - 1841. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. G. KLEBER and Y. RUDY Basic Mechanisms of Cardiac Impulse Propagation and Associated Arrhythmias Physiol Rev, April 1, 2004; 84(2): 431 - 488. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Roden Drug-Induced Prolongation of the QT Interval N. Engl. J. Med., March 4, 2004; 350(10): 1013 - 1022. [Full Text] [PDF]
|
|
|
|
|
|
D. M. Roden Cardiovascular Pharmacogenomics Circulation, December 23, 2003; 108(25): 3071 - 3074. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Anantharam, S. M. Markowitz, and G. W. Abbott Pharmacogenetic Considerations in Diseases of Cardiac Ion Channels J. Pharmacol. Exp. Ther., December 1, 2003; 307(3): 831 - 838. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Ackerman, D. J. Tester, G. S. Jones, M. L. Will, C. R. Burrow, and M. E. Curran Ethnic Differences in Cardiac Potassium Channel Variants: Implications for Genetic Susceptibility to Sudden Cardiac Death and Genetic Testing for Congenital Long QT Syndrome Mayo Clin. Proc., December 1, 2003; 78(12): 1479 - 1487. [Abstract] [PDF]
|
|
|
|
 |
|
 J. C. Makielski, B. Ye, C. R. Valdivia, M. D. Pagel, J. Pu, D. J. Tester, and M. J. Ackerman A Ubiquitous Splice Variant and a Common Polymorphism Affect Heterologous Expression of Recombinant Human SCN5A Heart Sodium Channels Circ. Res., October 31, 2003; 93(9): 821 - 828. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Balasubramaniam, A. A Grace, R. C Saumarez, J. I Vandenberg, and C. L-H Huang Electrogram prolongation and nifedipine-suppressible ventricular arrhythmias in mice following targeted disruption of KCNE1 J. Physiol., October 15, 2003; 552(2): 535 - 546. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. N. Obreztchikova, E. A. Sosunov, E. P. Anyukhovsky, N. S. Moise, R. B. Robinson, and M. R. Rosen Heterogeneous Ventricular Repolarization Provides a Substrate for Arrhythmias in a German Shepherd Model of Spontaneous Arrhythmic Death Circulation, September 16, 2003; 108(11): 1389 - 1394. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. J Paavonen, H. Chapman, P. J Laitinen, H. Fodstad, K. Piippo, H. Swan, L. Toivonen, M. Viitasalo, K. Kontula, and M. Pasternack Functional characterization of the common amino acid 897 polymorphism of the cardiac potassium channel KCNH2 (HERG) Cardiovasc Res, September 1, 2003; 59(3): 603 - 611. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. R. Bezzina, A. O. Verkerk, A. Busjahn, A. Jeron, J. Erdmann, T. T. Koopmann, Z. A. Bhuiyan, R. Wilders, M. M.A.M. Mannens, H. L. Tan, et al. A common polymorphism in KCNH2 (HERG) hastens cardiac repolarization Cardiovasc Res, July 1, 2003; 59(1): 27 - 36. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Milan, T. A. Peterson, J. N. Ruskin, R. T. Peterson, and C. A. MacRae Drugs That Induce Repolarization Abnormalities Cause Bradycardia in Zebrafish Circulation, March 18, 2003; 107(10): 1355 - 1358. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. L Tan, C. R Bezzina, J. P.P Smits, A. O Verkerk, and A. A.M Wilde Genetic control of sodium channel function Cardiovasc Res, March 15, 2003; 57(4): 961 - 973. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. D. Booker, S. D. Whyte, and E. J. Ladusans Long QT syndrome and anaesthesia Br. J. Anaesth., March 1, 2003; 90(3): 349 - 366. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Ansell, M. J. Ackerman, J. L. Black, L. R. Roberts, and A. Tefferi Primer on Medical Genomics Part VI: Genomics and Molecular Genetics in Clinical Practice Mayo Clin. Proc., March 1, 2003; 78(3): 307 - 317. [Abstract] [PDF]
|
|
|
|
 |
|
 B. Ye, C. R. Valdivia, M. J. Ackerman, and J. C. Makielski A common human SCN5A polymorphism modifies expression of an arrhythmia causing mutation Physiol Genomics, February 6, 2003; 12(3): 187 - 193. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Firouzi and W. A. Groenewegen Gene polymorphisms and cardiac arrhythmias Europace, January 1, 2003; 5(3): 235 - 242. [Full Text] [PDF]
|
|
|
|
|
|
E. Moric, E. Herbert, M. Trusz-Gluza, A. Filipecki, U. Mazurek, and T. Wilczok The implications of genetic mutations in the sodium channel gene (SCN5A) Europace, January 1, 2003; 5(4): 325 - 334. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. M. Roden The problem, challenge and opportunity of genetic heterogeneity in monogenic diseases predisposing to sudden death J. Am. Coll. Cardiol., July 17, 2002; 40(2): 357 - 359. [Full Text] [PDF]
|
|